1 Min Read
NEW YORK, Sept 26 (Reuters) - Catalyst Pharmaceutical Partners Inc : * Catalyst Pharma drops 18.5 percent to $1.50 in premarket after mid-stage results of cocaine addicition study delayed
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.